drug · protein
bintrafusp alfa
Phase 2updated 3mo agoby Merck KGaA🔗 ChEMBL
Phase 2community read0 votes
Protein drug with a maximum clinical stage of Phase 3 (across all indications), with 16 investigational indications.
targets
Programmed cell death 1 ligand 1Transforming growth factor beta
all catalysts(0)
nothing on the calendar yet
Trials studying bintrafusp alfa
- phase2Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma
- phase3Bintrafusp Alfa Program Rollover Study
- phase1Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)
- phase2Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPC
- phase1A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial Cancer
- phase1First in Human Study of M6223
- phase2Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer
- phase2M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1m ago
Found something off?
comments(0)
5-min edit window · permanent after that